Cervicogenic headache: the specific features of complex therapy with Amelotex and CompligamV

Cervicogenic headache: the specific features of complex therapy with Amelotex and CompligamV

An open-labeled study of the efficiency and tolerance of complex injection therapy with Amelotex in a dose of 15 mg/day for 6 days and CompligamV in a dose of one ampoule for 15 days was conduced in 30 patients (24 women and 6 men) aged 45 to 71 years with chronic cervicogenic headache (CGH) (its du...

Full description

Bibliographic Details
Main Author: M. L. Pospelova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2010-06-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
cervicogenic headache
amelotex
compligamv
combined therapy
endothelial dysfunction
efficiency
tolerability
open-label study
Online Access:https://nnp.ima-press.net/nnp/article/view/42

Internet

https://nnp.ima-press.net/nnp/article/view/42

Similar Items